The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Migraleve Film-coated Tablets

Johnson & Johnson (Ireland) LimitedPA0330/030/003

Main Information

Trade NameMigraleve Film-coated Tablets
Codeine phosphate
Dosage FormFilm-coated tablet
Licence HolderJohnson & Johnson (Ireland) Limited
Licence NumberPA0330/030/003

Group Information

ATC CodeN02BE Anilides
N02BE51 paracetamol, combinations excl. psycholeptics


License statusAuthorised
Licence Issued01/04/1978
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence6. Product not subject to medical prescription for pack sizes of up to 24 tablets. Product subject to prescription which may not be renewed for pack sizes of over 24 tablets. Supply through pharmacies only. 7.Promotion to healthcare professionals only and as a prescription-only medicine for pac
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back